Microbubbles/Ultrasound Contrast Agents Market Size, Share, Growth Analysis, By Disease Area(Cardio-vascular, Abdominal, Others), By Application(Diagnostic imaging, Drug delivery, Others), By End Use(Diagnostic centers, Hospitals, Others), By Region(North America, Europe, Asia-Pacific, Latin America), By Region - Industry Forecast 2024-2031

Microbubbles/Ultrasound Contrast Agents Market size was valued at USD 1.87 billion in 2022 and is poised to grow from USD 1.94 billion in 2023 to USD 2.66 billion by 2031, growing at a CAGR of 4.00% during the forecast period (2024-2031). 

A substance that is typically transparent to X-ray and is utilized in medical imaging to accelerate the contrast of fluids or structures is referred to as contrast media or contrast agent. For contrast ultrasound imaging, microbubbles are utilized as a blood pool agent in radiology and cardiology. Applications like gene therapy, drug delivery, molecular imaging, and stem cell delivery make extensive use of them.

Using ligand molecules that are restricted to disease-specific molecular markers, microbubbles can also function. The microbubble-based ultrasound contrast agents' primary functions include monitoring the biomarker condition of the vascular endothelium, imaging inflammation, observing the vasculature of tumors, and other tasks.

Microbubbles are injected intravenously and function similarly to red blood cells in the blood's circulation. When gas bubbles are subjected to general frequency ultrasound pulses, their diameters can vary, resulting in a powerful echo from the perfused tissue area.

The echogenicity and soft tissue surrounding of gasses differ greatly. As a result, utilizing microbubble contrast agents for ultrasonic diagnosis enhances the ultrasound reflection or backscattering, resulting in a distinctive echocardiogram with increased contrast.

US Microbubbles/Ultrasound Contrast Agents Market is poised to grow at a sustainable CAGR for the next forecast year.